About

Multiple myeloma is a cancer of plasma cells that weakens bones, causes anemia, and can lead to kidney damage and frequent infections. Iberdomide is a targeted therapy that modifies the cell's protein disposal system to mark cancerous plasma cells for destruction. By helping the body eliminate these harmful cells, iberdomide may slow disease progression and reduce symptoms in patients who've stopped responding to other treatments.